Bluefin Capital Management, LLC Astrazeneca PLC Transaction History

Bluefin Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $805,822 - $970,689	-14,462 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $24,957 - $29,489	462 Added 3.3%	14,462 $842,000
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $140,233 - $153,433	-2,524 Reduced 15.27%	14,000 $841,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $66,625 - $82,807	-1,376 Reduced 7.69%	16,524 $990,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $844,163 - $974,476	17,900 New	17,900 $890,000
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $450,847 - $539,121	-9,292 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $493,126 - $567,741	9,292 New	9,292 $510,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.